Atlas Trials

Database Evaluating Outcomes of Using Carbetocin as the Primary Uterotonic Following Cesarean Delivery

Clinical trial NCT03959436 · COMPLETED

Trial details

NCT number
NCT03959436
Sponsor
Maisonneuve-Rosemont Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
CarbetocinCesarean Section ComplicationsUterotonicsUterine Atony With Hemorrhage
Start date
2017-03-29
Primary completion
2018-03-16
Enrollment
612

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.